Literature DB >> 22427588

Impaired complex-I-linked respiration and ATP synthesis in primary open-angle glaucoma patient lymphoblasts.

Shanjean Lee1, Leo Sheck, Jonathan G Crowston, Nicole J Van Bergen, Evelyn C O'Neill, Fleur O'Hare, Yu Xiang George Kong, Vicki Chrysostomou, Andrea L Vincent, Ian A Trounce.   

Abstract

PURPOSE: Following the recent demonstration of increased mitochondrial DNA mutations in lymphocytes of POAG patients, the authors sought to characterize mitochondrial function in a separate cohort of POAG.
METHODS: Using similar methodology to that previous applied to Leber's hereditary optic neuropathy (LHON) patients, maximal adenosine triphosphate (ATP) synthesis and cellular respiration rates, as well as cell growth rates in glucose and galactose media, were assessed in transformed lymphocytes from POAG patients (n = 15) and a group of age- and sex-matched controls (n = 15).
RESULTS: POAG lymphoblasts had significantly lower rates of complex-I-driven ATP synthesis, with preserved complex-II-driven ATP synthesis. Complex-I driven maximal respiration was also significantly decreased in patient cells. Growth in galactose media, where cells are forced to rely on mitochondrial ATP production, revealed no significant differences between the control and POAG cohort.
CONCLUSIONS: POAG lymphoblasts in the study cohort exhibited a defect in complex-I of the oxidative phosphorylation pathway, leading to decreased rates of respiration and ATP production. Studies in LHON and other diseases have established that lymphocyte oxidative phosphorylation measurement is a reliable indicator of systemic dysfunction of this pathway. While these defects did not impact lymphoblast growth when the cells were forced to rely on oxidative ATP supply, the authors suggest that in the presence of a multitude of cellular stressors as seen in the early stages of POAG, these defects may lead to a bioenergetic crisis in retinal ganglion cells and an increased susceptibility to cell death.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427588     DOI: 10.1167/iovs.12-9596

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  41 in total

1.  Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma.

Authors:  Dongwook Lee; Myoung Sup Shim; Keun-Young Kim; You Hyun Noh; Heemin Kim; Sang Yeop Kim; Robert N Weinreb; Won-Kyu Ju
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-18       Impact factor: 4.799

2.  Molecular biomarkers in glaucoma.

Authors:  Sanjoy K Bhattacharya; Richard K Lee; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

Review 3.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

Review 4.  Lactate: More Than Merely a Metabolic Waste Product in the Inner Retina.

Authors:  Rupali Vohra; Miriam Kolko
Journal:  Mol Neurobiol       Date:  2020-01-08       Impact factor: 5.590

5.  The association of mitochondrial DNA haplogroups with POAG in African Americans.

Authors:  Harini V Gudiseva; Maxwell Pistilli; Rebecca Salowe; Larry N Singh; David W Collins; Brian Cole; Jie He; Sayaka Merriam; Naira Khachataryan; Jeffrey Henderer; Victoria Addis; Qi N Cui; Prithvi S Sankar; Eydie Miller-Ellis; Venkata R M Chavali; Gui-Shuang Ying; Douglas Wallace; Joan M O'Brien
Journal:  Exp Eye Res       Date:  2019-01-15       Impact factor: 3.467

6.  Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules.

Authors:  Alfred K Yu; Sandipan Datta; Marissa Z McMackin; Gino A Cortopassi
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

7.  Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma.

Authors:  Ji-Hong Wu; Sheng-Hai Zhang; John M Nickerson; Feng-Juan Gao; Zhongmou Sun; Xin-Ya Chen; Shu-Jie Zhang; Feng Gao; Jun-Yi Chen; Yi Luo; Yan Wang; Xing-Huai Sun
Journal:  Neurobiol Dis       Date:  2014-12-03       Impact factor: 5.996

8.  Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy.

Authors:  Fiona C Mansergh; Naomi Chadderton; Paul F Kenna; Oliviero L Gobbo; G Jane Farrar
Journal:  Eur J Hum Genet       Date:  2014-02-26       Impact factor: 4.246

9.  The presence of multiple cellular defects associated with a novel G50E iron-sulfur cluster scaffold protein (ISCU) mutation leads to development of mitochondrial myopathy.

Authors:  Prasenjit Prasad Saha; S K Praveen Kumar; Shubhi Srivastava; Devanjan Sinha; Gautam Pareek; Patrick D'Silva
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

10.  Hypothesis-independent pathway analysis implicates GABA and acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma.

Authors:  Jessica N Cooke Bailey; Brian L Yaspan; Louis R Pasquale; Michael A Hauser; Jae H Kang; Stephanie J Loomis; Murray Brilliant; Donald L Budenz; William G Christen; John Fingert; Douglas Gaasterland; Terry Gaasterland; Peter Kraft; Richard K Lee; Paul R Lichter; Yutao Liu; Catherine A McCarty; Sayoko E Moroi; Julia E Richards; Tony Realini; Joel S Schuman; William K Scott; Kuldev Singh; Arthur J Sit; Douglas Vollrath; Gadi Wollstein; Donald J Zack; Kang Zhang; Margaret A Pericak-Vance; R Rand Allingham; Robert N Weinreb; Jonathan L Haines; Janey L Wiggs
Journal:  Hum Genet       Date:  2014-07-19       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.